Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment

Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment.

MAIN RESULTS The groups did not differ for mortality (10%, 24%, 16%, and 16% in the etidronate only, calcium only, etidronate plus calcium, and no treatment groups, respectively); symptomatic fractures (6%, 8%, 10%, and 7%, respectively); or symptomatic fractures, semi quantitative vertebral fractures, or both (16%, 18%, 16%, and 20%, respectively). Groups receiving etidronate compared with gro...

Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

BACKGROUND Glucocorticoids are associated with a reduction in bone density and an increased risk of fracture. Concurrent treatment with bisphosphonates reduces bone loss and may prevent fractures. A randomised study was performed to determine whether treatment with cyclical etidronate and/or calcium for 5 years prevents fractures or reverses/reduces bone loss in patients receiving glucocorticoi...

modern surgical techniques in treatment of patients with cleft lip & cleft palate

چکیده ندارد.

Atorvastatin did not prevent cardiovascular events or death in patients with type 2 diabetes receiving hemodialysis.

Treatment with vitamin K in hip fracture patients receiving warfarin.

BACKGROUND Hip fractures are common in the elderly population, but surgical treatment of these fractures within the first 48 hours decreases morbidity and mortality. The management of patients with hip fracture requiring surgery who are taking warfarin anticoagulation is unclear. OBJECTIVES To determine the effect of vitamin K on hip fracture patients treated with warfarin. METHODS We retro...